MedPath

DIAZEPAM INJECTION SDZ

DIAZEPAM INJECTION SDZ

Discontinued
DIN Number

02386143

Drug Class

Human

Market Date

Mar 27, 2013

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02386143
AIG Number0103614001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05BA01 DIAZEPAM
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular ,  Intravenous
AHFS Classification28:24.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

DIAZEPAMActive
Strength: 10 MG / 2 ML
Monograph: DIAZEPAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.